CIMAX
Price
$27.54
Change
+$0.31 (+1.14%)
Updated
Jul 2 closing price
Net Assets
146.86B
WASAX
Price
$23.75
Change
+$0.03 (+0.13%)
Updated
Jul 2 closing price
Net Assets
1.84B
Interact to see
Advertisement

CIMAX vs WASAX

CIMAX vs WASAX Comparison Chart in %
View a ticker or compare two or three
VS
CIMAX vs. WASAX commentary
Jul 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CIMAX is a Buy and WASAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CIMAX has more cash in the bank: 147B vs. WASAX (1.85B). CIMAX pays higher dividends than WASAX: CIMAX (3.48) vs WASAX (1.64). CIMAX was incepted earlier than WASAX: CIMAX (24 years) vs WASAX (26 years). WASAX (1.12) is less costly to investors than CIMAX (0.59). WASAX (67.00) and CIMAX (65.00) have comparable annual turnover. WASAX initial investment is less costly to investors than CIMAX (4%) vs CIMAX (4%). CIMAX has a lower initial minimum investment than WASAX: CIMAX (250) vs WASAX (1000). CIMAX annual gain was more profitable for investors over the last year : 6.94 vs. WASAX (3.88). CIMAX return over 5 years is better than : 26.59 vs. WASAX (-0.13).
CIMAXWASAXCIMAX / WASAX
Total Expense Ratio0.591.1253%
Annual Report Gross Expense Ratio0.591.1253%
Fund Existence24 years26 years-
Gain YTD7.1206.503109%
Front Load4%6%61%
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets147B1.85B7,967%
Annual Yield % from dividends3.481.64212%
Returns for 1 year6.943.88179%
Returns for 3 years35.3232.22110%
Returns for 5 years26.59-0.13-20,312%
Returns for 10 years79.7029.77268%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VMVIX78.820.77
+0.99%
Vanguard Mid-Cap Value Index Investor
JEDTX19.640.13
+0.67%
Janus Henderson Global Sust Eq D
LMCQX37.260.05
+0.13%
Lord Abbett Mid Cap Stock R2
GERCX13.62-0.29
-2.08%
Goldman Sachs Em Mkts Eq Insghts C
RYMCX11.02-0.36
-3.16%
Royce Micro-Cap Consult